Author

D. Morgenstern

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Microbiology· 2 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 4 Assay:proteomics· 4 Approach:experimental assay· 3 Assay:bulk RNA-seq· 2 Approach:deep learning· 2 Research Focus:differential expression· 2 Organism:human· 2 Research Focus:protein folding & dynamics· 2

Frequent Co-Authors

Y. Levin· 2 shared A. Admon· 1 shared A. Beth-Din· 1 shared A. I. Nesvizhskii· 1 shared A. Javitt· 1 shared A. Kacen· 1 shared A. Malik· 1 shared A. Nachshon· 1 shared

Activity by Year

2018-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Y. Levin

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Deciphering the involvement of the Hippo pathway co-regulators, YAP/TAZ in invadopodia formation and matrix degradation

J. B. Venghateri, B. Dassa, D. Morgenstern, M. Shreberk-Shaked, M. Oren, B. Geiger

This study investigates the role of YAP/TAZ in invadopodia formation and matrix degradation in cancer cells, finding they suppress invadopodia formation and enhance matrix degradation when inhibited.

bioRxiv · Jun 28, 2022 · PreprintCancer Biology

Uncovering the modified immunopeptidome reveals insights into principles of PTM-driven antigenicity

A. Kacen, A. Javitt, M. P. Kramer, D. Morgenstern, T. Tsaban, A. Solomon, G. C. Teo, F. da Veiga Leprevost, E. Barnea, F. Yu, A. Admon, L. Eisenbach, G. Cafri, O. Schueler-Furman, Y. Levin, , Y. Merbl

The paper identifies thousands of novel cancer-specific antigens by analyzing PTMs in immunopeptidomics data from multiple sources and reveals their impact on HLA binding and TCR recognition.

bioRxiv · Apr 10, 2021 · PreprintCancer Biology

The coding capacity of SARS-CoV-2

Y. Finkel, O. Mizrahi, A. Nachshon, S. Weingarten-Gabbay, D. Morgenstern, Y. Yahalom-Ronen, H. Tamir, H. Achdout, D. Stein, O. Israeli, A. Beth-Din, S. Melamed, S. Weiss, T. Isrealy, N. Paran, , N. Stern-Ginossar

This study maps the full coding capacity of SARS-CoV-2 using ribosome profiling, identifying 23 novel translated ORFs and revealing viral translation dominance over host translation.

Nature · Sep 9, 2020Peer-reviewedMicrobiology

Optimization of skeletal protein preparation for LC-MS/MS sequencing yields additional coral skeletal proteins in Stylophora pistillata

Y. Peled, J. L. Drake, A. Malik, R. Almuly, M. Lalzar, D. Morgenstern, T. Mass

This study compares four protein purification methods from coral skeletons, identifying 60 proteins, 44 new to stony coral proteomes, and suggests non-traditional secretion pathways for skeletal protein transport.

bioRxiv · Mar 16, 2020Biochemistry

Expression of a recombinant, 4’-Phosphopantetheinylated, active M. tuberculosis Fatty acid Synthase I in E. coli

S. Baron, Y. Peleg, J. Grunwald, D. Morgenstern, N. Elad, M. Peretz, S. Albeck, Y. Levin, J. T. Welch, K. A. Deweerd, A. Schwartz, Y. Burstein, R. Diskin, Z. Shakked, O. Zimhony

This paper describes the expression and activation of Mtb FAS I in E. coli using AcpS, confirming its biochemical activity and structural properties.

bioRxiv · Aug 28, 2018Microbiology